Effects of Long-term Androgen Administration on Breast Tissue of Female-to-Male Transsexuals

Abstract

(EPD) S U M M A R Y Our aim was to examine the effects of androgen administration on breast tissue histology of female-to-male transsexuals and to study the immunohistochemical expression of three human tissue kallikreins, hK3 (PSA), hK6, and hK10. We studied 23 female-to-male transsexuals who were treated with injectable testosterone for 18-24 months. We also used 10 control female breast tissues. All tissues were fixed in buffered formalin, embedded in paraffin, and examined by hematoxylin-eosin staining and immunohistochemical staining for PSA, hK6, and hK10. Females treated with androgens exhibited similar involutionary changes as those seen in breast of menopausal women, such as marked reduction of glandular tissue, involution of the lobuloalveolar structures, and prominence of fibrous connective tissue, but presence of only small amounts of fat tissue. Fibrocystic lesions were generally not observed. In immunohistochemistry, in control breast tissues, we found moderate to strong cytoplasmic immunoexpression of hK6 and hK10 in the epithelial ductal and lobuloalveolar structures, but myoepithelial cells were negative. Luminal secretions were also positive. In menopausal breast, the immunoexpression of hK6 and hK10 was weaker and focal. No control case showed immunoexpression for PSA. In female-to-male transsexuals, one case showed focal PSA cytoplasmic immunoexpression in the epithelium of moderately involuting lobules. Long-term administration of androgens in female-to-male transsexuals causes marked reduction of glandular tissue and prominence of fibrous connective tissue. These changes are similar to those observed at the end-stage of menopausal mammary involution. (J Histochem Cytochem 54:905-910, 2006)

Safety of Physiological Testosterone Therapy in Women: Lessons from Female-to-Male Transsexuals (FMT) Treated with Pharmacological Testosterone Therapy

“…Most of these studies reported no serious adverse events with long‐acting T with the exception of a single case of breast carcinoma [48] and several cases of ovarian cancer. These changes are similar to those observed at the end‐stage of menopausal mammary involution [34,39,42,47].…”

Endocrine care of transpeople part I. A review of cross‐sex hormonal treatments, outcomes and adverse effects in transmen

“…Breast cancer . T usually induces a marked reduction of breast glandular tissue and an increase of fibrous connective tissue through growth‐inhibition and apoptotic effects . These changes are similar to those observed at the end‐stage of menopausal mammary involution .…”

Gender‐affirming hormone therapy and the risk of sex hormone‐dependent tumours in transgender individuals—A systematic review

“…Uniformly, these have shown that testosterone induces breast changes similar to menopause, notably a marked reduction in glandular tissue and increase in fibrous tissue. However, no malignancies were found in 152 total specimens identified across three studies …”